Breast Cancer Metastatic
13 drugs10,982 FAERS reportsMedDRA PT
GET
/api/v1/reaction/breast-cancer-metastaticReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Breast Cancer Metastatic (13)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Toripalimab110%
- 2Ribociclib1,5685.1%
- 3Fulvestrant1,6045.0%
- 4Exemestane8354.0%
- 5Medroxyprogesterone1,9463.8%
- 6Vinorelbine2493.7%
- 7Ibutilide13.4%
- 8Letrozole1,9683.2%
- 9Neratinib703.1%
- 10Estrogens2,1353.0%
- 11Alpelisib2422.8%
- 12Lonafarnib22.6%
- 13Lapatinib3612.3%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Metastases To Bone5 shared · 0.20
- Metastases To Liver3 shared · 0.16
- Breast Cancer Female2 shared · 0.11
- Breast Cancer3 shared · 0.11
- Palmar-plantar Erythrodysaesthesia Syndrome2 shared · 0.07
- Neoplasm Progression3 shared · 0.07
- Malignant Neoplasm Progression7 shared · 0.05
- Stomatitis3 shared · 0.04
- Electrocardiogram Qt Prolonged2 shared · 0.04
- White Blood Cell Count Decreased3 shared · 0.03
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.